Jac A Jones1, Yanin Chavarri-Guerra2, Luisa Barreto Costa Corrêa3, David R Dean4, Joel B Epstein5, Eduardo R Fregnani6, Jiyeon Lee7, Yuhei Matsuda8, Valeria Mercadante9, Ragnhild Elisabeth Monsen10, Natasja J H Rajimakers11, Deborah Saunders12, Enrique Soto-Perez-de-Celis13, Mariana S Sousa14, Arghavan Tonkaboni15, Arjan Vissink16, Keng Soon Yeoh17, Andrew N Davies18. 1. Royal Surrey County Hospital, Guildford, UK. 2. Department of Hemato-Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 3. State Health Department of the Federal District, Brasilia, Brazil. 4. Department of Oral Medicine, University of Washington/Seattle Cancer Care Alliance, Seattle, USA. 5. City of Hope Comprehensive Cancer Center, Duarte & Cedars Sinai Health System, Los Angeles, USA. 6. Instituto Sírio-Libanês de Ensino E Pesquisa, Sao Paulo, Brazil. 7. College of Nursing & Mo-Im Kim Nursing Research Institute, Yonsei University, Seoul, South Korea. 8. Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Japan. 9. Royal National ENT & Eastman Dental Hospitals, London, UK. 10. Department of Medicine, Lovisenberg Diaconal Hospital & Department for Interdisciplinary Health Sciences, University of Oslo, Oslo, Norway. 11. Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. 12. Department of Dental Oncology, Health Services North, Northern Ontario School of Medicine, Sudbury, Canada. 13. Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 14. IMPACCT, Faculty of Health, University of Technology Sydney, Sydney, Australia. 15. Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran. 16. Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. 17. Special Needs Dental Unit, South Australia Dental Service, Adelaide, Australia. 18. Trinity College Dublin, University College Dublin & Our Lady's Hospice Dublin, Trinity College Dublin, Dublin, Ireland. andavies@tcd.ie.
Abstract
PURPOSE: The Palliative Care Study Group in conjunction with the Oral Care Study Group of the Multinational Association for Supportive Care in Cancer (MASCC) formed a sub-group to develop evidence-based guidance on the management of common oral problems in patients with advanced cancer. METHODS: This guidance was developed in accordance with the MASCC Guidelines Policy. A search strategy for Medline was developed, and the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials were explored for relevant reviews and trials, respectively. Guidance was categorised by the level of evidence, and "category of guideline" (i.e., "recommendation", "suggestion" or "no guideline possible"). RESULTS: Twelve generic suggestions (level of evidence - 5), three problem-specific recommendations and 14 problem-specific suggestions were generated. The generic suggestions relate to oral hygiene measures, assessment of problems, principles of management, re-assessment of problems and the role of dental/oral medicine professionals. CONCLUSIONS: This guidance provides a framework for the management of common oral problems in patients with advanced cancer, although every patient requires individualised management.
PURPOSE: The Palliative Care Study Group in conjunction with the Oral Care Study Group of the Multinational Association for Supportive Care in Cancer (MASCC) formed a sub-group to develop evidence-based guidance on the management of common oral problems in patients with advanced cancer. METHODS: This guidance was developed in accordance with the MASCC Guidelines Policy. A search strategy for Medline was developed, and the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials were explored for relevant reviews and trials, respectively. Guidance was categorised by the level of evidence, and "category of guideline" (i.e., "recommendation", "suggestion" or "no guideline possible"). RESULTS: Twelve generic suggestions (level of evidence - 5), three problem-specific recommendations and 14 problem-specific suggestions were generated. The generic suggestions relate to oral hygiene measures, assessment of problems, principles of management, re-assessment of problems and the role of dental/oral medicine professionals. CONCLUSIONS: This guidance provides a framework for the management of common oral problems in patients with advanced cancer, although every patient requires individualised management.
Authors: Valeria Mercadante; Siri Beier Jensen; Derek K Smith; Kari Bohlke; Jessica Bauman; Michael T Brennan; Robert P Coppes; Niels Jessen; Narinder K Malhotra; Barbara Murphy; David I Rosenthal; Arjan Vissink; Jonn Wu; Deborah P Saunders; Douglas E Peterson Journal: J Clin Oncol Date: 2021-07-20 Impact factor: 44.544